Ram Aiyar, PhD

Ram Aiyar serves as Chief Executive Officer and President of Korro Bio, holding a seat on its board of directors. With nearly two decades of expertise spanning biotech and pharma, he excels in all phases from inception to commercialization. Ram’s background includes leadership roles at Corvidia Therapeutics, culminating in its acquisition by Novo Nordisk for $2.1B. He began his career in research at Janssen Pharmaceuticals and holds advanced degrees from Drexel University and INSEAD.